Atlas Trials

FDG-PET/CT Imaging as Early Predictor of DP

Clinical trial NCT02476734 · COMPLETED

Trial details

NCT number
NCT02476734
Sponsor
Abramson Cancer Center at Penn Medicine
Status
COMPLETED
Study type
OBSERVATIONAL
Lymphoma
Start date
2014-08-01
Primary completion
2016-02-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.